Uncategorized
9 Analysts Have This To Say About Haemonetics
Latest Ratings for HAE Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Needham Downgrades Buy Hold Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for HAE View the Latest Analyst Ratings read more
Jimmy Kimmel Back On ABC Tuesday, But Not Everyone Will Get To See Late Night Show
“Jimmy Kimmel Live!” returns Tuesday night, but some areas in the country will be unable to watch the show on their local ABC station. read more
Coinbase Prime Powers CaliberCos’ LINK Treasury Strategy
CaliberCos chose Coinbase to provide institutional trading and custody for its Digital Asset Treasury strategy on Chainlink’s LINK token. read more
What’s Going On With CoreWeave (CRWV) Stock Tuesday?
CoreWeave shares are trading marginally higher Tuesday morning. The stock’s upward momentum is fueled by positive sentiment surrounding the artificial intelligence sector. read more
Accenture Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Latest Ratings for ACN Date Firm Action From To Mar 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Initiates Coverage On Neutral Dec 2021 Barclays Maintains Overweight View More Analyst Ratings for ACN View the Latest Analyst Ratings read more
What’s Going On With Kenvue Stock Tuesday?
Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with increase risk of autism. read more
Scholar Rock’s Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection
FDA cites Catalent Indiana issues in Scholar Rock’s SMA drug review; European approval decision expected in 2026, with Germany as the launch market. read more